Table 3.

Association between brachial FMD (%) and height adjusted baseline brachial diameter with cardiovascular risk factors/medication use in the adjusted linear regression model^*

Variable	Brachial FMD (%) (Mean ± se)	P value	Baseline Diameter (mm) (Mean ± se)	P value
Age (years)
≤ median	3.12 ± 0.05	0.009	4.48 ± 0.02	0.007
> median	2.93 ± 0.05		4.55 ± 0.02
Gender
Females	3.30 ± 0.05	<0.0001	4.13 ± 0.02	<0.0001
Males	2.66 ± 0.06		5.04 ± 0.02
Race
Caucasians	3.13 ± 0.04	<0.0001	4.47 ± 0.01	<0.0001
Blacks	2.55 ± 0.09		4.72 ± 0.03
Cholesterol (mg/dl)
≤ median	3.03 ± 0.05	0.825	4.51 ± 0.02	0.680
> median	3.04 ± 0.05		4.50 ± 0.02
Diabetes mellitus
No	3.05 ± 0.04	0.372	4.49 ± 0.01	0.002
Yes	2.96 ± 0.10		4.62 ± 0.04
Hypertension
No	3.18 ± 0.06	0.0004	4.43 ± 0.02	<0.0001
Yes	2.89 ± 0.05		4.58 ± 0.02
Cigarette smoking
No	3.01 ± 0.05	0.415	4.52 ± 0.02	0.240
Yes	2.89 ± 0.14		4.46 ± 0.05
ACE inhibitor use
No	3.05 ± 0.04	0.290	4.52 ± 0.01	0.084
Yes	2.94 ± 0.10		4.46 ± 0.03
HMG CoA red. Use
No	3.04 ± 0.04	0.790	4.51± 0.01	0.960
Yes	3.01 ± 0.10		4.51 ± 0.04
β Blocker use
No	3.02 ± 0.04	0.155	4.51 ± 0.01	0.31
Yes	3.16 ± 0.09		4.48 ± 0.03

^*Each stratified analysis is adjusted for all covariates including age, gender, race, total cholesterol, HDL, hypertension, diabetes mellitus, cigarette smoking, β blocker use, ACE inhibitor use and HMG CoA reductase inhibitor use